Literature DB >> 20446930

Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.

Katarzyna Gustaw-Rothenberg1, Krystyna Kowalczuk, Marta Stryjecka-Zimmer.   

Abstract

AIM: Although a large body of evidence supports a role of oxidative stress in the etiopathogenesis of dementia, there is still a substantial lack of data regarding the biomarkers of oxidative stress characteristic of Alzheimer's disease (AD) as opposed to different types of dementia. In this study, the level of various oxidative stress parameters were measured in AD, vascular dementia (VaD), and age- and sex-matched control patients. The AD and VaD patients all had similar levels of cognitive impairment as measured by the Mini-Mental State Examination.
METHODS: Thirty AD, 19 VaD and 29 controls patients were recruited to the study. Plasma levels of malondialdehyde (MDA), total sulfhydryl (T-SH), calcium (Ca(++)) and magnesium (Mg(++)) were measured.
RESULTS: In both AD and VaD groups, the levels of oxidative stress parameters were higher compared with controls. Further, the VaD patients expressed significantly higher levels of plasma parameters of oxidative stress than AD. The difference was noted in MDA, the marker of lipid peroxidation, whereas in VaD the level of MDA was more than 2.8-fold higher than that registered in AD patients.
CONCLUSION: Vascular dementia in patients is characteristic of increased levels of oxidative stress, especially lipid peroxidation markers. This finding is relevant to determining the pathophysiology of dementia, particularly in the light of the recently suggested importance of the vascular component in dementia development, in addition to aiding in the diagnosis of VaD following clinical presentation. The study will be continued to compare the character and level of decline in both groups.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446930     DOI: 10.1111/j.1447-0594.2009.00571.x

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  28 in total

Review 1.  Emerging molecular mechanisms of vascular dementia.

Authors:  Milagros C Romay; Camilo Toro; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 2.  Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.

Authors:  Melissa A Bradley-Whitman; Mark A Lovell
Journal:  Arch Toxicol       Date:  2015-04-18       Impact factor: 5.153

3.  Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment.

Authors:  Claudius Mueller; Matthew Schrag; Andrew Crofton; Jens Stolte; Martina U Muckenthaler; Shino Magaki; Wolff Kirsch
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Effects of a Short-Term Lipopolysaccharides Challenge on Mouse Brain and Liver Peroxisomal Antioxidant and β-oxidative Functions: Protective Action of Argan Oil.

Authors:  Soukaina Essadek; Habiba Bouchab; Riad El Kebbaj; Catherine Gondcaille; Soufiane El Kamouni; Stéphane Savary; Joseph Vamecq; Abdelkhalid Essamadi; Mustapha Cherkaoui-Malki; Boubker Nasser; Pierre Andreoletti
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-12

5.  Alzheimer's disease improved through the activity of mitochondrial chain complexes and their gene expression in rats by boswellic acid.

Authors:  Tarek M Mohamed; Menna Allah M Youssef; Azza A Bakry; Mai M El-Keiy
Journal:  Metab Brain Dis       Date:  2020-11-07       Impact factor: 3.584

Review 6.  Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors.

Authors:  Tapan Behl; Dapinder Kaur; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Gokhan Zengin; Felicia Liana Andronie-Cioara; Mirela Marioara Toma; Simona Bungau; Adrian Gheorghe Bumbu
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

7.  Comparison of taurine, GABA, Glu, and Asp as scavengers of malondialdehyde in vitro and in vivo.

Authors:  Yan Deng; Wei Wang; Pingfeng Yu; Zhijiang Xi; Lijian Xu; Xiaolong Li; Nongyue He
Journal:  Nanoscale Res Lett       Date:  2013-04-24       Impact factor: 4.703

8.  Changes in phospholipid composition of erythrocyte membrane in Alzheimer's disease.

Authors:  Shinji Oma; Shiro Mawatari; Kazuyuki Saito; Chikako Wakana; Yoshio Tsuboi; Tatsuo Yamada; Takehiko Fujino
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-08-15

Review 9.  The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia.

Authors:  Maria Luca; Antonina Luca; Carmela Calandra
Journal:  Oxid Med Cell Longev       Date:  2015-08-02       Impact factor: 6.543

10.  Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer's disease.

Authors:  Natividad López-Riquelme; Jordi Alom-Poveda; Nuria Viciano-Morote; Isabel Llinares-Ibor; Consuelo Tormo-Díaz
Journal:  SAGE Open Med       Date:  2016-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.